The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model. (Q53956744)

22 May 2018

title

The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model. (English)

1 reference

22 May 2018

main subject

multiple drug resistance

1 reference

1 reference

Steven Warmann

1

1 reference

22 May 2018

Mona Hunger

2

1 reference

22 May 2018

Birgit Teichmann

3

1 reference

22 May 2018

Peer Flemming

4

1 reference

22 May 2018

Klaus Friedrich Gratz

5

1 reference

22 May 2018

Jörg Fuchs

6

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 October 2002

1 reference

22 May 2018

published in

Cancer

1 reference

22 May 2018

volume

95

1 reference

22 May 2018

issue

8

1 reference

22 May 2018

page(s)

1795-1801

1 reference

22 May 2018

The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

P-glycoprotein--a mediator of multidrug resistance in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

MDR1 gene expression in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Pharmacological considerations in the modulation of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Clinical trials of P-glycoprotein reversal in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Increased intracellular drug accumulation and complete chemosensitization achieved in multidrug-resistant solid tumors by co-administering valspodar (PSC 833) with sterically stabilized liposomal doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Modulation of multidrug resistance by SDZ PSC 833 in leukemic and solid-tumor-bearing mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Successful therapy of subcutaneously growing human hepatoblastoma xenografts with topotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

Prognostic factors and staging systems in childhood hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

7 January 2021

Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

7 January 2021

Expression of a multidrug resistance gene in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

7 January 2021

Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

7 January 2021

Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

7 January 2021

Successful transplantation of human hepatoblastoma into immunodeficient mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

7 January 2021

Cremophor EL reversed multidrug resistance in vitro but not in tumor-bearing mouse models

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10858

7 January 2021

Identifiers

DOI

10.1002/CNCR.10858

1 reference

22 May 2018

1 reference

22 May 2018